No, Rykster is right. Recce is functionally more similar to a disinfectant like methylated spirits than a traditional antibiotic. That's why it also works on viruses, same as how a disinfectant also work on viruses. Also why it's "broad spectrum" and "bacteria can't evolve to resist it", just like a disinfectant. Antibiotics usually need to bind to specific proteins on the cell wall, if the bacteria mutates and that protein changes it won't bind anymore. But Recce attaches to the cell wall on a more basic level, it doesn't matter what kind of proteins it has, it'll pop it anyway, similar to a disinfectant.
Don't get too caught up on categories like "disinfectant" or "antibiotic". Those are just terms we use to describe what chemicals do. But Recce really is a genuinely new class of chemical, completely different to anything else. It doesn't fit into those traditional categories. Saying it's like a disinfectant is not an insult at all, it's a compliment.
If you could drink enough alcohol to kill the bugs in your blood without killing you too... well, we wouldn't need antibiotics would we. That's why Recce is so interesting, it really is a disinfectant you can inject. Theoretically anyway... And that's the crux of the matter, how much Recce can you inject before side effects happen, and is that dosage still enough to meaningfully kill the bugs. The animal toxicity tests are good so I'm betting on yes, but... the operative word there is "betting".
Guys, go to the prospectus https://hotcopper.com.au/threads/ann-prospectus.2678699/ page 22 onwards. It goes into more detail on what Recce is, how it works.
- Forums
- ASX - By Stock
- Ann: Top 20 Shareholders Update
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

No, Rykster is right. Recce is functionally more similar to a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online